Gottlieb Nomination Draws Positive Reviews, And Some Questions

The administration’s plan to nominate Scott Gottlieb as FDA commissioner drew generally positive reactions on Capitol Hill and from drugmakers — but also some concerns from other stakeholders over his strong industry ties.
Source: Drug Industry Daily